Multi-omic profiling in pulmonary arterial hypertension

P. Otero-Núñez (London, United Kingdom), C. Rhodes (London, United Kingdom), J. Wharton (London, United Kingdom), E. Swietlik (Cambridge, United Kingdom), S. Kariotis (Sheffield, United Kingdom), L. Harbaum (London, United Kingdom), M. Dunning (Sheffield, United Kingdom), J. Elinoff (Bethesda, United States of America), N. Errington (Sheffield, United Kingdom), R. Thomson (Sheffield, United Kingdom), J. Iremonger (Sheffield, United Kingdom), G. Coghlan (London, United Kingdom), P. Corris (Newcastle, United Kingdom), L. Howard (London, United Kingdom), D. Kiely (Sheffield, United Kingdom), C. Church (Glasgow, United Kingdom), J. Pepke-Zaba (Papworth, United Kingdom), M. Toshner (Cambridge, United Kingdom), S. Wort (London, United Kingdom), A. Desai (Indianapolis, United States of America), M. Humbert (Paris, France), W. Nichols (Cincinnati, United States of America), . Southgate (London, United Kingdom), D. Trégouët (Bordeaux, France), R. Trembath (London, United Kingdom), I. Prokopenko (Surrey, United Kingdom), S. Gräf (Cambridge, United Kingdom), N. Morrell (Cambridge, United Kingdom), D. Wang (Sheffield, United Kingdom), A. Lawrie (Sheffield, United Kingdom), M. Wilkins (London, United Kingdom)

Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension
Session: Genetics and genomics of pulmonary arterial hypertension
Session type: Oral Presentation
Number: 4458
Disease area: Pulmonary vascular diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Otero-Núñez (London, United Kingdom), C. Rhodes (London, United Kingdom), J. Wharton (London, United Kingdom), E. Swietlik (Cambridge, United Kingdom), S. Kariotis (Sheffield, United Kingdom), L. Harbaum (London, United Kingdom), M. Dunning (Sheffield, United Kingdom), J. Elinoff (Bethesda, United States of America), N. Errington (Sheffield, United Kingdom), R. Thomson (Sheffield, United Kingdom), J. Iremonger (Sheffield, United Kingdom), G. Coghlan (London, United Kingdom), P. Corris (Newcastle, United Kingdom), L. Howard (London, United Kingdom), D. Kiely (Sheffield, United Kingdom), C. Church (Glasgow, United Kingdom), J. Pepke-Zaba (Papworth, United Kingdom), M. Toshner (Cambridge, United Kingdom), S. Wort (London, United Kingdom), A. Desai (Indianapolis, United States of America), M. Humbert (Paris, France), W. Nichols (Cincinnati, United States of America), . Southgate (London, United Kingdom), D. Trégouët (Bordeaux, France), R. Trembath (London, United Kingdom), I. Prokopenko (Surrey, United Kingdom), S. Gräf (Cambridge, United Kingdom), N. Morrell (Cambridge, United Kingdom), D. Wang (Sheffield, United Kingdom), A. Lawrie (Sheffield, United Kingdom), M. Wilkins (London, United Kingdom). Multi-omic profiling in pulmonary arterial hypertension. 4458

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The genetics of pulmonary arterial hypertension
Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Year: 2005

Towards a molecular classification of pulmonary arterial hypertension
Source: Eur Respir J 2016; 48: 987-989
Year: 2016


Elevated pulmonary capillary pressure in pulmonary arterial hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 3s
Year: 2001

Single arterial occlusion to locate resistance in patients with pulmonary hypertension
Source: Eur Respir J 2003; 21: 31-36
Year: 2003



The revolution of pulmonary arterial hypertension
Source: Eur Respir Rev 2016; 25: 361-363
Year: 2016


Pulmonary arterial hypertension
Source: ISSN=ISSN 1810-6838, ISBN=, page=397
Year: 2007

Pulmonary arterial hypertension
Source: Eur Respir Monogr 2013; 62: 70-84
Year: 2013


Pulmonary arterial hypertension
Source: Eur Respir Monogr 2014; 66: 232-246
Year: 2014


Pulmonary arterial hypertension
Source: ISSN=ISSN 1810-6838, ISBN=, page=126
Year: 2005

Pulmonary arterial hypertension
Source: Breathe 2010; 6: 377-380
Year: 2010

Pulmonary arterial hypertension
Source: International Congress 2018 – State of the art session: Pulmonary vascular diseases
Year: 2018


Towards an understanding of pulmonary arterial hypertension (PAH): gene regulation patterns in pulmonary arterial resistance vessels of patients with PAH
Source: Eur Respir J 2006; 28: Suppl. 50, 526s
Year: 2006

Trends in pulmonary arterial hypertension
Source: Eur Respir Rev 2009; 18: 7-12
Year: 2009

Pulmonary arterial hypertension in children
Source: Eur Respir J 2003; 21: 155-176
Year: 2003



Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension
Source: Eur Respir J 2010; 35: 6-8
Year: 2010


The future of treatment for pulmonary arterial hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017

The future of treatment for pulmonary arterial hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014

The future of treatment for pulmonary arterial hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018

The future of treatment for pulmonary arterial hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012